| Patents for A61P 25 - Drugs for disorders of the nervous system (183,225) |
|---|
| 08/08/1995 | CA1336601C Optical isomers |
| 08/05/1995 | CA2141907A1 Virus msrvl and pathogen agent and/or msrv2 associated with multiple sclerosis, their nucleic constituants and their applications |
| 08/04/1995 | CA2141729A1 N-(3-aminopropyl)-n-phenyl-5,6,7,8-tetrahydro-naphthalene -2-carboxamide derivatives, their preparation and their therapeutic use |
| 08/04/1995 | CA2141728A1 3-(2-aminoethyl)-4-¬3-(trifluoromethyl)benzoyl|-3, 4-dihydro-2h-1,4- benzoxazine derivatives, process for their preparation and their therapeutic application |
| 08/03/1995 | WO1995020588A1 Indole derivatives as 5-ht1 agonists |
| 08/03/1995 | WO1995020587A1 Neuroprotective chroman compounds |
| 08/03/1995 | WO1995020578A1 SUBSTITUTED AROMATIC COMPOUNDS AS c.AMP PHOSPHODIESTERASE- AND TNF-INHIBITORS |
| 08/03/1995 | WO1995020575A1 Aralkylamino substituted azacyclic therapeutic agents |
| 08/03/1995 | WO1995020568A1 Pharmaceutical product comprising a salicylate of an esterifiable beta-blocker |
| 08/03/1995 | WO1995020402A1 Antioxidants and intracellular glutathione raising agents for therapeutic treatments |
| 08/03/1995 | WO1995004720A3 Gastrin and cck receptor ligands |
| 08/03/1995 | CA2182489A1 Antioxidants and intracellular glutathione raising agents for therapeutic treatments |
| 08/03/1995 | CA2182219A1 Pharmaceutical product comprising a salicylate of an esterifiable beta-blocker |
| 08/03/1995 | CA2181475A1 Indole derivatives as 5-ht1 agonists |
| 08/03/1995 | CA2181376A1 Aralkylamino substituted azacyclic therapeutic agents |
| 08/02/1995 | EP0664832A1 Remyelination using neural stem cells |
| 08/02/1995 | EP0664810A1 3,3-disubstituted tri- and tetracyclic indolin-2-ones useful for the treatment of cognitive disorders |
| 08/02/1995 | EP0664804A1 Benzofuran derivatives as 5-ht1-like receptor antagonists |
| 08/02/1995 | EP0664801A1 Amide derivatives |
| 08/02/1995 | EP0664794A1 N-alkylpiperidinyl-4-methyl carboxylic esters/amides of condensed ring systems as 5-ht4 receptor antagonists |
| 08/02/1995 | EP0664788A1 Substituted ethanolamine esters |
| 08/02/1995 | EP0664695A1 Method and composition for treating muco-epidermal and epidermal pain, inflammation and infection |
| 08/02/1995 | EP0544765B1 Piperazinyl derivatives with affinity for 5-HT receptors |
| 08/02/1995 | EP0505519B1 Kava extract, method of preparing the extract, and its use |
| 08/02/1995 | EP0386232B1 Nasal administration of benzodiazepine hypnotics |
| 08/02/1995 | CN1106008A 4-aryloxy-and 4-arylthiopiperidine derivatives |
| 08/02/1995 | CN1106007A Novel sulfonylamino pyrimidines |
| 08/02/1995 | CN1105998A Naphthoxazines |
| 08/02/1995 | CN1105990A Phenylalkanolamine derivatives |
| 08/02/1995 | CN1105989A Tricyclic 1-aminoethylpyrrol derivative |
| 08/02/1995 | CN1105988A 1-amino-ethylindole-derivatives |
| 08/02/1995 | CN1029404C Process for preparation of alpha-adrenergic receptor antagonists |
| 08/02/1995 | CN1029403C 2-oxo-1-oxa-8-azaspiro|4,5¨ decane derivatives, pharmaceutical compositions containing them and process for preparing-same |
| 08/01/1995 | US5438063 Hypotensive agents, cardiac insufficiency, increased intraocular pressure, and CNS disorders |
| 08/01/1995 | US5437874 Pharmaceutical composition for the preparation of a stable powder containing an association of acetylsalicylic acid and metoclopramide as the active ingredients |
| 08/01/1995 | CA1336514C Cyclo-octane neuroprotective agents |
| 08/01/1995 | CA1336502C Nasal administration of benzodiazepine hypnotics |
| 08/01/1995 | CA1336490C Pharmacological treatment of ocular development |
| 08/01/1995 | CA1336488C Dosage form having reduced abuse potential |
| 07/27/1995 | WO1995019985A1 Haemopoietic maturation factor |
| 07/27/1995 | WO1995019968A1 Aromatic 2-amino-imidazole derivatives as alpha-2a adrenoceptor agonists |
| 07/27/1995 | WO1995019960A1 Monoamine oxidase b inhibitors, processes for their preparation and use thereof |
| 07/27/1995 | WO1995019771A1 Indole diterpene alkaloid compounds |
| 07/27/1995 | CA2181431A1 Haemopoietic maturation factor |
| 07/27/1995 | CA2181371A1 Indole diterpene alkaloid compounds |
| 07/27/1995 | CA2180956A1 Monoamine oxidase b inhibitors, processes for their preparation and use thereof |
| 07/27/1995 | CA2126361A1 Gene encoding cationic amino acid transporter protein |
| 07/26/1995 | EP0664127A2 Pharmaceutical compositions containing isoquinoline derivatives |
| 07/26/1995 | EP0663912A1 Heterocyclic ether compounds that enhance cognitive function |
| 07/26/1995 | EP0663911A1 Benzopyranones, method of preparing them and their use. |
| 07/26/1995 | EP0663839A1 Ibuprofen-h 2? antagonist combinations |
| 07/26/1995 | EP0663832A1 Use of 4'-iodo-4'-deoxydoxorubicin for the treatment of amyloidosis |
| 07/26/1995 | EP0663825A1 Use of melatonin to induce sleep |
| 07/26/1995 | EP0663824A1 Potassium channel activating compounds and methods of use thereof |
| 07/26/1995 | EP0663822A1 Methods and compositions for treating hypertension, angina and other disorders using optically pure s(-) nitrendipine |
| 07/26/1995 | EP0663819A1 Ibuprofen-caffeine combinations |
| 07/26/1995 | EP0416037B1 Superoxide dismutase analogs having novel binding properties |
| 07/25/1995 | US5436348 Sleep disorders |
| 07/25/1995 | US5436261 Benzospiroalkene heterocyclic compounds |
| 07/25/1995 | US5436246 Serotonin receptor agents |
| 07/25/1995 | US5436241 Topical anti-inflammatory compositions containing piroxicam |
| 07/25/1995 | US5436233 Nervous system disorders |
| 07/25/1995 | CA1336436C Gamma aminobutyric acid agonists and their use in the treatment of depression and senile dementia and other forms of memory impairment |
| 07/25/1995 | CA1336431C Thiazolo(5,4-b)azepine compounds |
| 07/25/1995 | CA1336428C Substituted dibenzocycloheptenimines |
| 07/20/1995 | WO1995019435A2 T cell antigen receptor v region proteins and methods of preparation thereof |
| 07/20/1995 | WO1995019356A1 Endopeptidase 24.15 inhibitor |
| 07/20/1995 | WO1995019344A1 Gem-disubstituted azacyclic tachykinin antagonists |
| 07/20/1995 | WO1995019170A1 Application of riluzole in the treatment of mitochondrial diseases |
| 07/20/1995 | CA2181171A1 T cell antigen receptor v region proteins and methods of preparation thereof |
| 07/20/1995 | CA2180746A1 Gem-disubstituted azacyclic tachykinin antagonists |
| 07/19/1995 | EP0663209A2 Medicament for inhibiting the effects of amyloidogenic proteins |
| 07/19/1995 | EP0662971A1 DERIVATIVES OF 5H,10H-IMIDAZO 1,2-a]INDENO 1,2-e]PYRAZINE-4-ONE, PREPARATION THEREOF AND MEDICAMENTS CONTAINING THEM |
| 07/19/1995 | EP0662962A1 Substituted pyrimidines for control of diabetic complications |
| 07/19/1995 | EP0662959A1 5-ht4 antagonists |
| 07/19/1995 | EP0662948A1 2-amino-4-phenyl-4-oxo-butyric acid derivatives with kynureninase and/or kynurenine-3-hydroxylase inhibiting activity |
| 07/19/1995 | EP0662834A1 Novel epoxide-containing compounds |
| 07/19/1995 | EP0662832A1 Oral compositions containing 1,2,5,6-tetrahydro-1-methyl-3-pyridinecarboxyaldehyde-o-methyl-oxime |
| 07/19/1995 | EP0662831A1 3-substituted 2-oxindole-1-carboxamide pharmaceutical compositions |
| 07/19/1995 | EP0662827A1 Therapeutic and diagnostic methods and compositions based on notch proteins and nucleic acids |
| 07/19/1995 | CN1105360A 1-|2H-1-benzopyran-2-one-8yl¨-piperazin derivative |
| 07/19/1995 | CN1105358A N-substituted azabicycloheptane derivatives, the preparation and use thereof |
| 07/19/1995 | CN1105266A Hypnotic body-building bath lotion containing Chinese medicine |
| 07/18/1995 | US5434184 Chemical compounds |
| 07/18/1995 | US5434178 1,3,5 trisubstituted pyrazole compounds for treatment of inflammation |
| 07/18/1995 | US5434177 Imidazoles for the treatment of age-related cognitive disorders and alzheimer |
| 07/18/1995 | US5434174 Isoxazole derivatives for the treatment of irritable bowel syndrome |
| 07/18/1995 | US5434168 4-[(2-benzothiazolyl)methylamino]-alpha-[(3,4-difluorophenoxy)methyl]-1-piperidineethanol |
| 07/18/1995 | US5434167 Imidazolines N-substituted by a biphenylmethyl group, their medical use and the pharmaceutical compositions therefor |
| 07/18/1995 | US5434166 Methods of inhibiting demyelinating and desmyelinating diseases |
| 07/18/1995 | US5434158 Asthma |
| 07/18/1995 | US5434156 Use of diphenylbutyl-piperazinecarboxamides in the treatment of substance disorders |
| 07/18/1995 | US5434154 Serotonin agonists |
| 07/18/1995 | US5434149 Phosphodiesterase inhibitors |
| 07/18/1995 | US5434142 Method of treatment for muscular dystrophy |
| 07/18/1995 | CA1336333C Pyrrolidone-2 compounds and their use for central analgesic activity |
| 07/13/1995 | WO1995018856A1 Vertebrate embryonic pattern-inducing hedgehog-like proteins |
| 07/13/1995 | WO1995018810A1 Hydrazides of phosphorylated carboxylic acids having therapeutic activity |
| 07/13/1995 | WO1995018793A1 Novel heterocyclic compounds |
| 07/13/1995 | WO1995018625A1 The composition containing snapping turtle and tortoise, the preparation and the use thereof |